- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06800495
Development of THALEA Kit and Its Impact on Knowledge, Attitude, and Intention for Premarital Thalassemia Screening (THALEA)
Development of THALEA (Thalassemia Education and Awareness) Kit and a Cluster Randomised Control Trial to Evaluate Its Effectiveness on Knowledge, Attitude, and Intention Regarding Premarital Thalassemia Screening Among Private Secondary School Students of Klang Valley, Malaysia
Thalassemia, a common genetic disease, is often overlooked compared to infectious diseases like HIV, despite its significant effects for families planning to have children. Thalassemia carriers are frequently asymptomatic, but when two carriers marry, there is a 25% chance of having a child with a severe form of the disease. Although screening programs exist, the number of symptomatic thalassemia major continues to increase, and current treatments are primarily symptomatic, merely prolonging survival rather than curing it.
In Malaysia, while HIV testing before marriage is mandatory, thalassemia screening is not. Presently, thalassemia screening and awareness programs are offered to fourth-form students in government schools only. Hence, there is a need to complement existing national screening efforts by creating a standardized thalassemia awareness program that can be effectively implemented across diverse educational institutions.
Our main objective is to develop and validate the THALEA (Thalassemia education and awareness) kit and evaluate its effectiveness among secondary school students in Klang Valley, Malaysia. We hope that with this intervention, high school students are be able to increase their awareness and knowledge, instil a positive attitude and have that intention to do a pre-marital thalassemia screening at any healthcare facility in our country. This can facilitate early detection and timely counselling to reduce the risk of having children with severe thalassemia.
Delivery of the intervention:
i. Schools will be approached by letter, followed by a phone call and a visit. ii. Consent forms will be given for parents to sign. iii. All fourth form students at the school will be invited to participate in the study, excluding those who meet the exclusion criteria.
iv. THALEA will be delivered by a face-to-face method between the main researcher and the students.
v. Frequency of delivery - one time only vi. Duration of intervention - 2-3 hours. vii. The intervention group will receive THALEA along with a basic family health education. THALEA's session comprises a face-to-face verbal presentation facilitated by the primary researcher, featuring an engaging interactive seminar and on-screen games. Following this, participants will be presented with 3-5-minute videos and pictorial materials, fostering two-way discussions. Subsequently, a softcopy of the THALEA kit will be distributed to the teacher in charge via email or WhatsApp after the seminar for further dissemination. The students will receive THALEA's brochures.
viii. The comparison group will only receive a basic family health education in which it is the usual family health education given by the MOH, usually delivered by a medical officer, to fourth form students at government schools prior to the thalassemia screening programme. It will consist of a delivery of a PowerPoint presentation and videos, that will be obtained from government public health clinics in Klang Valley.
We will use a self-administered questionnaire designed and validated to assess knowledge, attitude, and intention regarding premarital thalassemia screening among youths at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and 2 weeks post assessment (t2)
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Selangor
-
Sungai Buloh, Selangor, Malaysia, 47000
- University Teknologi MARA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Malaysians.
- Fourth form students.
- Able to read and write in either Malay or the English language.
Exclusion Criteria:
- Those who have previously undergone thalassemia screening
- Identified as thalassemia carriers
- Without parental consent or assent
- Has first-degree relatives diagnosed with thalassemia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
vii.
The intervention group will receive THALEA along with a basic family health education.
THALEA's session comprises a face-to-face verbal presentation facilitated by the primary researcher, featuring an engaging interactive seminar and on-screen games.
Following this, participants will be presented with 3-5-minute videos and pictorial materials, fostering two-way discussions.
Subsequently, a softcopy of the THALEA kit will be distributed to the teacher in charge via email or WhatsApp after the seminar for further dissemination.
The students will receive THALEA's brochures.
|
By using the opinions obtained by the experts, THALEA's content will then be designed using the Theory of Planned Behaviour (TPB) by Ajzen and Fishbein. Development of THALEA: • Language: Malay and English. • Contents of the THALEA kit: i. PowerPoint or Canva presentations with discussion prompts (softcopy form) ii. Links/joining codes to free educational game platforms such as Kahoot or Quizziz iii. Videos - convey messages on thalassemia awareness and screening importance. iv. Illustrated guides/brochures - to provide step-by-step tutorials on how to get thalassemia screening in both the public and private healthcare. • Developer would be the main researcher with aid from: i. Illustrator ii. Video graphic designer iii. Influencers • Delivery of THALEA to students by: i. Medical personnel
Other Names:
|
|
Active Comparator: Comparison arm
viii.
The comparison group will only receive a basic family health education in which it is the usual family health education given by the MOH, usually delivered by a medical officer, to fourth form students at government schools prior to the thalassemia screening programme.
It will consist of a delivery of a PowerPoint presentation and videos, that will be obtained from government public health clinics in Klang Valley.
|
They are basic family health education in which it is the usual family health education given by the MOH, usually delivered by a medical officer, to fourth form students at government schools prior to the thalassemia screening programme.
It will consist of a delivery of a PowerPoint presentation and videos, that will be obtained from government public health clinics in Klang Valley.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge and attitude score
Time Frame: i. All students will be given 5 minutes to fill in their demographic information ii. Then 10 to 15 minutes will be given to answer the questionnaire at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and
|
Knowledge and attitude score will be calculated by using the filled in self-administered questionnaire designed and validated to assess knowledge, attitude, and intention regarding premarital thalassemia screening among youths
|
i. All students will be given 5 minutes to fill in their demographic information ii. Then 10 to 15 minutes will be given to answer the questionnaire at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intention regarding premarital thalassemia screening
Time Frame: i. All students will be given 5 minutes to fill in their demographic information ii. Then 10 to 15 minutes will be given to answer the questionnaire at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and
|
This will also be calculated using the same questionnaire.
|
i. All students will be given 5 minutes to fill in their demographic information ii. Then 10 to 15 minutes will be given to answer the questionnaire at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- THALEA
- Other funds (Other Identifier: UiTM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thalassemia
-
University of California, San FranciscoRecruitingAlpha-Thalassemia | Alpha Thalassemia Major | Alpha Thalassemia MinorUnited States
-
Guangzhou Women and Children's Medical CenterRecruitingThalassemia Majors (Beta-Thalassemia Major) | Haplo-identical DonorsChina
-
Agios Pharmaceuticals, Inc.Active, not recruitingNon-Transfusion-dependent Alpha-Thalassemia | Non-Transfusion-dependent Beta-ThalassemiaSpain, Denmark, Thailand, Malaysia, United States, Netherlands, Italy, Canada, Greece, Brazil, France, United Kingdom, United Arab Emirates, Bulgaria, Saudi Arabia, Taiwan, Turkey (Türkiye), Lebanon
-
Agios Pharmaceuticals, Inc.Active, not recruitingTransfusion-dependent Alpha-Thalassemia | Transfusion-dependent Beta-ThalassemiaSpain, Taiwan, Thailand, United States, France, Canada, Malaysia, Germany, Netherlands, Italy, Bulgaria, United Kingdom, Greece, United Arab Emirates, Brazil, Denmark, Saudi Arabia, Lebanon, Turkey (Türkiye)
-
Editas Medicine, Inc.Active, not recruitingHemoglobinopathies | Thalassemia Major | Thalassemia Intermedia | Transfusion Dependent Beta ThalassemiaUnited States, Canada
-
Shiraz University of Medical SciencesCompletedCombination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermediaβ-Thalassemia IntermediaIran, Islamic Republic of
-
Assiut UniversityNot yet recruitingThalassemia Majors (Beta-Thalassemia Major)
-
CelgeneTerminatedBeta Thalassemia Intermedia | Beta Thalassemia MajorFrance, United Kingdom, Italy, Greece
-
Agios Pharmaceuticals, Inc.Not yet recruitingTransfusion-dependent Alpha-Thalassemia | Transfusion-dependent Beta-Thalassemia
-
Ataturk UniversityNot yet recruitingBeta Thalassemia Major | Thalassemia Majors (Beta-Thalassemia Major)Turkey
Clinical Trials on THALEA (Thalassemia Education and Awareness) Kit
-
University of WashingtonNational Institute for Occupational Safety and Health (NIOSH/CDC)CompletedHeat Stress DisordersUnited States
-
Seva Canada SocietyReiyukai Eiko Masunaga Eye Hospital (REMEH); Pragyaan Sustainable Health Outcomes...Not yet recruiting
-
National Institute of Diabetes and Digestive and...Completed
-
NYU Langone HealthActive, not recruitingSkin CancerUnited States
-
University of FloridaCompletedMeningococcal VaccineUnited States
-
University of BergenHaukeland University Hospital; Bergen University CollegeCompleted
-
Karabuk UniversityActive, not recruitingHelp-Seeking Behavior | School Health | Focus | Symptom AwarenessTurkey (Türkiye)
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBurnout, Professional | Mental Health Wellness 1 | Self EfficacyUnited States
-
Indiana UniversityPatient-Centered Outcomes Research Institute; Four County Counseling Center; Places...CompletedBurnout | Quality of CareUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedSubstance Use Disorders | Alcohol Use DisorderTurkey